BackInozyme Pharma Overview

Inozyme Pharma Net Income

Profitability analysis for INZY.

Quarterly Net Income

-$28.04M
↓ 20.1% YoY

As of Mar 2025

Annual Net Income (TTM)

-$106.72M
↓ 38.39% YoY

Trailing 12 months ending Mar 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin